Bayer gets €500m floater tight to curve

By Jon Hay
28 Mar 2014

Bayer, the German chemical company, tapped into the growing demand for floating rate notes on Tuesday with a €500m no-grow three year deal.

Once this would have been seen as daring – now it is run of the mill. A banker at one of the leads, Goldman Sachs, JP Morgan and Royal Bank of Scotland, said issuing in floating or fixed rate form over a short maturity did not necessarily make ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial